Histone Lactylation Drives Pazopanib Resistance in Renal Cell Carcinoma
A study reveals that HDAC11 deficiency promotes histone lactylation and metabolic reprogramming to drive pazopanib resistance in renal cell carcinoma ...
A study reveals that HDAC11 deficiency promotes histone lactylation and metabolic reprogramming to drive pazopanib resistance in renal cell carcinoma ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.